Low levels of the endogenous endocannabinoid arachidonoylethanolamide are predictive of symptomatic in-stent restenosis after coronary implantation of drug-eluting stents / Vignali, L., Talanas, G., Menozzi, A., Cattabiani Maria, A., Solinas, E., Emanuele, E., Ardissino, D.. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 51:10(2008), pp. B93-B93.
Low levels of the endogenous endocannabinoid arachidonoylethanolamide are predictive of symptomatic in-stent restenosis after coronary implantation of drug-eluting stents
Vignali L;
2008-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
